Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
SR-18292
Cat. No.:
OB0225LY-0293
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
SR-18292 is a small molecule compound with a unique chemical structure that shows potential in cell signaling and metabolic regulation.
Synonym:
SR 18292; 2095432-55-4; 1-((1H-Indol-4-yl)oxy)-3-(tert-butyl(4-methylbenzyl)amino)propan-2-ol; 1-[tert-butyl-[(4-methylphenyl)methyl]amino]-3-(1H-indol-4-yloxy)propan-2-ol
CAS No.:
2095432-55-4
Compound CID:
129896798
Formula:
C23H30N2O2
Formula Weight:
366.5
Specification
Relative Density:
1.132 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
SR-18292 can be used to study the regulation of cell signaling pathways or play an important role in metabolic disease models.
Library Information
Targets:
Nuclear receptors/transcription factors
Receptors:
PGC-1α
Pathways:
Autophagy; Metabolism
Plate Number:
AOCL-4
Plate Location:
g4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 150.06 mM
Ethanol Max Solubility:
10 mg/mL
Solubility:
Insoluble in water.
ALogP:
4.736
HBA_Count:
1
HBD_Count:
2
Rotatable Bond:
8
